Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China
· Delayed Price · Currency is CNY 9.39
-0.06 (-0.63%)
At close: Mar 9, 2026
Xiangxue Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,209 | 6,461 | 3,406 | 3,961 | 5,266 | 5,842 | Upgrade
|
| Market Cap Growth | -8.48% | 89.71% | -14.02% | -24.79% | -9.85% | 1.02% | Upgrade
|
| Enterprise Value | 8,707 | 9,128 | 6,159 | 6,816 | 9,064 | 9,617 | Upgrade
|
| Last Close Price | 9.39 | 9.77 | 5.15 | 6.07 | 8.07 | 8.95 | Upgrade
|
| PE Ratio | - | - | - | - | - | 59.36 | Upgrade
|
| Forward PE | - | 11.93 | 11.93 | 11.93 | 11.93 | 11.93 | Upgrade
|
| PS Ratio | 4.22 | 3.48 | 1.48 | 1.81 | 1.77 | 1.90 | Upgrade
|
| PB Ratio | 5.65 | 4.49 | 1.47 | 1.46 | 1.40 | 1.38 | Upgrade
|
| P/TBV Ratio | - | 437.03 | 4.23 | 3.47 | 3.20 | 3.07 | Upgrade
|
| P/FCF Ratio | 101.84 | - | 16.42 | - | - | - | Upgrade
|
| P/OCF Ratio | 76.09 | 355.48 | 12.93 | 17.42 | 20.45 | 22.72 | Upgrade
|
| EV/Sales Ratio | 5.92 | 4.91 | 2.68 | 3.12 | 3.05 | 3.13 | Upgrade
|
| EV/EBITDA Ratio | - | - | 21.82 | 113.06 | 72.50 | 21.51 | Upgrade
|
| EV/EBIT Ratio | - | - | 123.98 | - | - | 30.84 | Upgrade
|
| EV/FCF Ratio | 142.79 | - | 29.69 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 2.02 | 1.56 | 1.05 | 0.90 | 0.92 | 0.93 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 8.48 | 38.38 | 27.04 | 8.86 | Upgrade
|
| Debt / FCF Ratio | 36.36 | - | 11.73 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 1.90 | 1.46 | 0.99 | 0.84 | 0.82 | 0.78 | Upgrade
|
| Net Debt / EBITDA Ratio | -17.14 | -133.61 | 8.09 | 38.01 | 24.64 | 7.38 | Upgrade
|
| Net Debt / FCF Ratio | 34.30 | -122.94 | 11.01 | -16.38 | -10.10 | -6.61 | Upgrade
|
| Asset Turnover | 0.19 | 0.24 | 0.27 | 0.22 | 0.25 | 0.30 | Upgrade
|
| Inventory Turnover | 3.28 | 3.86 | 3.54 | 2.69 | 2.78 | 2.62 | Upgrade
|
| Quick Ratio | 0.18 | 0.19 | 0.19 | 0.18 | 0.28 | 0.39 | Upgrade
|
| Current Ratio | 0.27 | 0.30 | 0.35 | 0.32 | 0.44 | 0.55 | Upgrade
|
| Return on Equity (ROE) | -62.41% | -45.91% | -15.96% | -15.58% | -16.45% | 3.39% | Upgrade
|
| Return on Assets (ROA) | -2.67% | -1.85% | 0.37% | -1.09% | -0.12% | 1.89% | Upgrade
|
| Return on Invested Capital (ROIC) | -10.06% | -5.75% | 1.03% | -2.96% | -0.31% | 3.85% | Upgrade
|
| Return on Capital Employed (ROCE) | -25.00% | -11.10% | 1.60% | -5.10% | -0.50% | 5.80% | Upgrade
|
| Earnings Yield | -16.15% | -13.29% | -11.42% | -13.38% | -13.07% | 1.69% | Upgrade
|
| FCF Yield | 0.98% | -0.26% | 6.09% | -3.53% | -5.79% | -8.54% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 208.23% | Upgrade
|
| Buyback Yield / Dilution | -0.41% | -0.18% | 0.50% | -0.09% | -0.89% | -2.90% | Upgrade
|
| Total Shareholder Return | -0.41% | -0.18% | 0.50% | -0.09% | -0.89% | -2.90% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.